Dr. Justin M. Sacks, MD

Dr. Sacks practices at Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health.

Dr. Sacks' NPI, 1497835946, was assigned on October 17, 2006. Dr. Sacks graduated from Icahn School of Medicine at Mount Sinai in 1998. Dr. Sacks holds Missouri license 2020005824.

Dr. Sacks' primary practice is Barnes-Jewish Hospital, at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 747-3000. Dr. Sacks also practices at Barnes-Jewish Hospital, 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110.

Dr. Sacks' primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. Dr. Sacks is also affiliated with Barnes-Jewish West County Hospital. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Sacks to 1 more hospital, 2 group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sacks practices, 6 sites in all. Vendor and product names are available with a free account.

Plastic surgery is Dr. Sacks' primary specialty in the NPI Registry, under taxonomy code 208200000X. Dr. Sacks is licensed in Missouri.

CMS data shows 115 Medicare services from Dr. Sacks across 4 procedure codes in 2024, for 77 Medicare patients. Medicare paid $9,375 for them.

CMS counts 77 Medicare patients who saw Dr. Sacks in 2024. The largest group is 65 to 74, with 33 patients. 64% of them have high blood pressure, and 58% have cancer. 22% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sacks' median patient age at 62, with 81% women.

In 2024, Dr. Sacks wrote 62 Medicare Part D claims for 23 patients. 95% of them were for generic drugs. CMS names the drug for 29 of them, across 2 drugs with 11 or more claims each, at $939 in total drug cost. In 2023, CMS named 49 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Sacks for performance year 2024, reported as part of a group. Dr. Sacks accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sacks as offering telehealth. CMS counts 32 procedures of mastectomy by Dr. Sacks, more than 88% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 180 papers to Dr. Sacks, published from 2011 to 2025. 2023 was the busiest year, with 20. The most frequent topics are Breast Neoplasms, Postoperative Complications and Mammaplasty. Dr. Sacks has published most often in Plast Reconstr Surg. Dr. Sacks' most frequent co-authors are Gedge David Rosson, MD, Franca Kraenzlin, MD and Damon Sean Cooney, MD.

Dmand AI links Dr. Sacks to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Amputation, Traumatic, Cicatrix and Fibrosis.

CMS Open Payments shows 240 general payments to Dr. Sacks from 29 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 51% of the total. Allergan Inc. paid the most, $101,534.

Dr. Sacks graduated from Icahn School of Medicine at Mount Sinai in 1998.